Aminolevulinic Acid

CHEMBL601 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

131.1 g/mol

LogP

-3.8

Phase

4

A naturally occurring compound in the body's heme synthesis pathway that, when given in excess, accumulates as protoporphyrin IX in rapidly dividing cells, making them selectively sensitive to light-based destruction in photodynamic therapy. It is also used to improve the visualization of malignant brain and bladder tumors during surgery.

分子量

131.1300 g/mol

LogP

-3.80

TPSA

80.40 Å²

リピンスキーの五則

適合

治療領域

Melanoma Ovarian Cancer Bladder Cancer Pain Management Insomnia Lymphoma Type 2 Diabetes Breast Cancer Chronic Pain Malaria Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

NCC(=O)CCC(=O)O

InChI

InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)

Molecular Formula

C5H9NO3

HBD / HBA

2 / 4

回転可能結合数

4

重原子数

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A naturally occurring compound in the body's heme synthesis pathway that, when given in excess, accumulates as protoporphyrin IX in rapidly dividing cells, making them selectively sensitive to light-based destruction in photodynamic therapy. It is also used to improve the visualization of malignant brain and bladder tumors during surgery.

Yes, Aminolevulinic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL601. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 137. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Aminolevulinic Acid PillFYIで

構造

クイックデータ

分子式: C5H9NO3
同義語: 3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.